tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Mannkind Corp. (MNKD)
NASDAQ:MNKD
US Market
MNKD
MannKind
RESEARCH TOOLSreports

MannKind (MNKD) Stock News & Sentiment

Compare
2,034 Followers
MannKind Targets Newly Diagnosed Youth With Afrezza: What Investors Should Watch
Premium
Company Announcements
MannKind Targets Newly Diagnosed Youth With Afrezza: What Investors Should Watch
14d ago
MNKD
Multiple 2026 Regulatory, Pipeline, and Partnership Catalysts Underscore MannKind’s Underappreciated Growth Potential and Support Reiterated Buy Rating
Premium
Ratings
Multiple 2026 Regulatory, Pipeline, and Partnership Catalysts Underscore MannKind’s Underappreciated Growth Potential and Support Reiterated Buy Rating
22d ago
MNKD
3 ‘Strong Buy’ Stocks to Buy Today,12/24/2025, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Today,12/24/2025, According to Top Analysts
1M ago
NOW
ENGN
MannKind’s Clofazimine Inhalation Study Terminated: Implications for Investors
Premium
Company Announcements
MannKind’s Clofazimine Inhalation Study Terminated: Implications for Investors
2M ago
MNKD
MannKind’s Strategic Advancements and Product Potential Justify Buy Rating Despite MNKD-101 Discontinuation
Premium
Ratings
MannKind’s Strategic Advancements and Product Potential Justify Buy Rating Despite MNKD-101 Discontinuation
3M ago
MNKD
MannKind’s Resilience and Growth Potential: A Buy Rating Amid Setbacks and Opportunities
Premium
Ratings
MannKind’s Resilience and Growth Potential: A Buy Rating Amid Setbacks and Opportunities
3M ago
MNKD
MannKind Halts Phase 3 Trial for MNKD-101
Premium
Company Announcements
MannKind Halts Phase 3 Trial for MNKD-101
3M ago
8K
MNKD
More MNKD News >

MNKD News on the Web

Analysts Offer Insights on Healthcare Companies: Humana (HUM), MannKind (MNKD) and Inspire Medical Systems (INSP)
TipRanks News
Bullish
HC Wainwright & Co. Reiterates 'Buy' Rating for MNKD with $11 Target | MNKD Stock News
GuruFocus News
Bullish
Morning Movers: USA Rare Earth surges after government funding pact
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: MannKind (MNKD), Perspective Therapeutics (CATX)
TipRanks News
Bullish
FDA Approves Label Update for MannKind's (MNKD) Afrezza Insulin
GuruFocus News
Bullish
MannKind receives FDA approval for Afrezza dosage label
TipRanks News
Bullish
FDA Approves Updated Afrezza Label, Easing Transition from Injections and Pumps: What This Means for Patients and Providers
Market Chameleon
Bullish
MannKind Targets Newly Diagnosed Youth With Afrezza: What Investors Should Watch
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
MNKD
Sector Average
Media Buzz
This Week7 articles
Weekly Average4.25 articles
News Sentiment
This Week100%
Sector Average74%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MNKD’s Media Buzz Sentiment?
7 articles about MNKD were published this week. In an average week, 4.25 articles are published.
    What is MNKD’s weekly average amount of articles?
    In an average week, 4.25 articles about MNKD are published.
      What is MNKD’s News Sentiment?
      100% of articles about MNKD were positive this week, compared to its sector average of 74%.
        Healthcare Stocks that are Trending in the News
        HOCPFHOYA
        CBLControl Bionics Ltd.
        CRDFCardiff Oncology
        KRROKorro Bio
        IMAImageneBio
        Showing the stocks with the most bullish news sentiment over the past week